Skip to main content

Advertisement

Log in

HPV Detection Methods in Head and Neck Cancer

  • Invited Review
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Human papillomavirus (HPV) infection is emerging as a major prognostic and predictive marker in head and neck squamous cell carcinoma (HNSCC). Researches are focused on the development of HPV detection assays specially designed for HNSCC. The HPV diagnosis in these tumours is relevant toprognosis even in an already-developed tumour, whereas in the cervix, where the HPV is the cause of almost all tumours, this information has less clinical relevance. The better outcome of HPV-associated HNSCC raises the question about the best methodologies to distinguish between HPV and non-HPV-associated SCC. However, no consensus has been reached on the optimal way to identify HPV-associated SCC and ancillary studies have utilised many different methodologies, including HPV polymerase chain reaction testing, HPV in situ hybridization analysis, immunohistochemical staining for p16, and newer techniques that are currently under investigation. The objective of this review is to explain and give examples of various techniques of HPV detection highlighting how they might be used clinically. Although currently insufficiently specific due to the possibility of HPV infection originating at other sites, methodologies utilising serum and plasma to measure HPV infection will also be described, mostly for their potential future development and use. Finally, DNA/RNA microarray platforms will be briefly summarized for their capacity to identify the profile of molecular changes in any particular HPV+/HPV− cancer. In this way, it is expected to be possible to correlate the appropriate transcriptome-based diagnosis to the patients’ specific cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Syrjänen KJ, Pyrhönen S, Syrjänen SM, et al. Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions. Br J Oral Surg. 1983;21:147–53.

    Article  PubMed  Google Scholar 

  2. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.

    Article  PubMed  CAS  Google Scholar 

  3. Venuti A, Manni V, Morello R, et al. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol. 2000;60:396–402.

    Article  PubMed  CAS  Google Scholar 

  4. Yeudall WA, Campo MS. Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol. 1991;72:173–6.

    Article  PubMed  CAS  Google Scholar 

  5. Nuovo GJ. In situ detection of human papillomavirus DNA after PCR-amplification. Methods Mol Biol. 2011;688:35–46.

    Article  PubMed  CAS  Google Scholar 

  6. Agoston ES, Robinson SJ, Mehra KK, et al. Polymerase chain reaction detection of HPV in squamous carcinoma of the oropharynx. Am J Clin Pathol. 2010;134:36–41.

    Article  PubMed  Google Scholar 

  7. Snijders PJ, Heideman DA, Meijer CJ. Methods for HPV detection in exfoliated cell and tissue specimens. APMIS 2010;118:520–8 (Review).

    Google Scholar 

  8. Gheit T, Landi S, Gemignani F, et al. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol. 2006;44:2025–31.

    Article  PubMed  CAS  Google Scholar 

  9. Remmerbach TW, Brinckmann UG, Hemprich A, et al. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol. 2004;30:302–8.

    Article  PubMed  CAS  Google Scholar 

  10. Schmitt M, Bravo IG, Snijders PJ, et al. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol. 2006;44:504–12.

    Article  PubMed  CAS  Google Scholar 

  11. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121:2465–72.

    Article  PubMed  CAS  Google Scholar 

  12. Badaracco G, Venuti A, Morello R, et al. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res. 2000;20:1301–5.

    PubMed  CAS  Google Scholar 

  13. Badaracco G, Rizzo C, Mafera B, et al. Molecular analyses and prognostic relevance of HPV in head and neck tumours. Oncol Rep. 2007;17:931–9.

    PubMed  CAS  Google Scholar 

  14. Mellin H, Dahlgren L, Munck-Wikland E, et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer. 2002;102:152–8.

    Article  PubMed  CAS  Google Scholar 

  15. Molden T, Kraus I, Skomedal H, et al. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J Virol Methods. 2007;142:204–12.

    Article  PubMed  CAS  Google Scholar 

  16. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–301.

    Article  PubMed  Google Scholar 

  17. Ukpo OC, Flanagan JJ, Ma XJ, et al. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35:1343–50.

    Article  PubMed  Google Scholar 

  18. Bishop JA, Maleki Z, Valsamakis A, et al. Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status. Cancer Cytopathol. 2011 Jul 12. Epub ahead of print]).

  19. Lidqvist M, Nilsson O, Holmgren J, et al. Detection of human papillomavirus oncoprotein E7 in Liquid-based cytology using monoclonal antibodies. J Gen Virol. 2011; Oct 19 [Epub ahead of print].

  20. Chen PC, Pan CC, Kuo C, et al. Risk of oral nonmalignant lesions associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan: an integrated molecular and epidemiologic study. Arch Pathol Lab Med. 2006;130:57–61.

    PubMed  Google Scholar 

  21. Lewis S Jr, Thorstad WL, Chernock RD, et al. P16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol. 2010;34:1088–96.

    Article  PubMed  Google Scholar 

  22. Thavaraj S, Stokes A, Guerra E, et al. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol. 2011;64:308–12.

    Article  PubMed  Google Scholar 

  23. Harris SL, Thorne LB, Seaman WT, et al. Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck. 2010; Dec 28 [Epub ahead of print].

  24. Martinez I, Wang J, Hobson KF, et al. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer. 2007;43:415–32.

    Article  PubMed  CAS  Google Scholar 

  25. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344:1125–31.

    Article  PubMed  CAS  Google Scholar 

  26. Anderson KS, Wong J, D’Souza G, et al. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br J Cancer. 2011;104:1896–905.

    Article  PubMed  CAS  Google Scholar 

  27. Di Lonardo A, Marcante ML, Poggiali F, et al. HPV 16 E7 antibody levels in cervical cancer patients: before and after treatment. J Med Virol. 1998;54:192–5.

    Article  PubMed  Google Scholar 

  28. Rubenstein LM, Smith EM, Pawlita M, et al. Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study. Infect Agent Cancer. 2011;6:9.

    Article  PubMed  Google Scholar 

  29. Le QT, Jones CD, Yau TK, et al. A comparison study of different PCR assays in measuring circulating plasma Epstein-Barr virus DNA levels in patients with nasopharyngeal carcinoma. Clin Cancer Res. 2005;11:5700–7.

    Article  PubMed  CAS  Google Scholar 

  30. Capone RB, Pai SI, Koch WM, et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPVassociated head and neck squamous cell carcinoma. Clin Cancer Res. 2000;6:4171–5.

    PubMed  CAS  Google Scholar 

  31. Fakhry C, Rosenthal BT, Clark DP, et al. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal “pap-test equivalent” in high-risk populations. Cancer Prev Res (Phila). 2011;4:1378–84.

    Article  Google Scholar 

Download references

Acknowledgments

Work partially supported by a grant from the Italian Ministry of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aldo Venuti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Venuti, A., Paolini, F. HPV Detection Methods in Head and Neck Cancer. Head and Neck Pathol 6 (Suppl 1), 63–74 (2012). https://doi.org/10.1007/s12105-012-0372-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-012-0372-5

Keywords

Navigation